Biostatistics hiring at venture-backed biotech is a small-pool game — there are more open Director of Biostatistics roles than there are qualified candidates. Recruits Lab runs biostat searches from a maintained network of trial-experienced biostatisticians rather than starting from cold outreach.
Biostatistics is the discipline that decides whether a trial readout is interpretable. A weak statistician chooses the wrong endpoint, misses an adaptive design opportunity, or under-powers a study that ultimately reads negative on a real signal. The cost of a wrong biostatistics hire is rarely the recruiting fee — it is the trial that fails to support a meaningful conclusion.
Recruits Lab places biostatistics talent across early-phase and late-phase trial design, statistical programming (SAS, R, Python), and biometrics leadership for venture-backed biotech and specialty pharma. Our practice spans Statistician through Director and VP of Biometrics levels.
Our recruiters understand the distinctions that matter — biostatisticians with real adaptive design experience versus those who have only run fixed designs, programmers with CDISC fluency versus surface familiarity, and biometrics leaders with submission ownership versus those who have only supported submissions. We screen for ownership.
Many biostatistics searches at venture-backed companies fail because the role sits between scientific, regulatory, and clinical operations functions. The candidate must talk to all three groups credibly. We screen for that communication skill explicitly.
Subscription pricing makes this work for venture-backed teams building out a biometrics function. A flat monthly fee with unlimited active roles is the right structure when you need to make multiple biometrics hires in a quarter.
Why this market is hard to recruit for. And how we solve each one.
True adaptive design ownership is rarer than resumes suggest. We screen for direct experience versus theoretical familiarity.
SDTM and ADaM fluency varies widely among programmers. We screen for hands-on depth.
Few biometrics leaders have actually owned a successful NDA or BLA submission. We screen for direct ownership.
CRO-trained biostatisticians can transition sponsor-side but require cultural calibration. We screen for the shift.
Biostatisticians must talk credibly to clinical, regulatory, and scientific teams. We assess for communication explicitly.
Senior biostatistics talent is in chronic short supply. We manage offer and resign conversations directly.
The repeatable system behind our 14-day average hire time.
We run a deep intake call with hiring managers and scientific leadership covering technical must-haves, dealbreakers, comp band, equity philosophy, and the cultural traits that predict success in your specific stage and program.
We build a fresh map of 80-150 qualified candidates from direct competitors, academic spinouts, CROs, and adjacent therapeutic areas. No database scraping — real research from a recruiter who understands the science.
Personalized outreach from a senior recruiter who can actually discuss your molecule, mechanism, or modality. Response rates run 3-5x higher than generalist agencies because the first message reads like it came from another scientist.
Five to eight vetted candidates with structured profile briefs covering technical fit, motivation, publication record where relevant, comp expectations, and risk factors. Not a resume dump — a decision document.
We manage offer construction, counter-offer scenarios, resign coaching, and start-date negotiation. Every placement carries a 90-day replacement guarantee at no additional fee.
Original observations from live searches in this specialty.
Biostatisticians who have personally defended statistical analysis plans in FDA meetings — pre-IND, End-of-Phase 2, pre-BLA — are a small and highly-mapped list. We source against this list specifically when a program is nearing a regulatory milestone.
Sponsor-side biostat leadership requires judgment about study design, indication, and program strategy that CRO biostat rarely develops. We split the CRO pool based on whether the candidate has been the sponsor-facing biostat voice on their prior programs.
In rare disease and adaptive trial programs, biostatistical judgment is a top-3 driver of trial success. We deliberately shortlist for candidates with adaptive design and Bayesian methods experience when the program design calls for it.
2026 U.S. base salary ranges for biostatistics roles at venture-backed and mid-cap life sciences companies. Excludes equity, bonus, and sign-on. Ranges reflect Series A through commercial-stage benchmarks.
| Role | Base Salary Range |
|---|---|
| Biostatistician II | $130K–$170K |
| Senior Biostatistician | $160K–$210K |
| Principal Biostatistician | $195K–$255K |
| Statistical Programmer III | $135K–$175K |
| Manager, Biostatistics | $185K–$240K |
| Director, Biostatistics | $235K–$305K |
| VP, Biometrics | $330K–$435K |
Source: Recruits Lab 2026 Life Sciences Compensation dataset.
Quick answers to the questions founders and hiring leaders ask most.
Biostatistics recruiters source, screen, and qualify statisticians, programmers, and biometrics leadership for biotech and pharma trials. Recruits Lab specializes in biostatistics and averages 14 days from kickoff to offer.
Industry average for director and VP-level biostatistics is 90 to 150 days. Recruits Lab averages 14 days.
Yes. SAS, R, and Python programmers with CDISC fluency are a routine practice area.
Subscription starts at $7,500 per month with unlimited active roles. Contingency is a flat 20 percent with a 90-day guarantee.
Yes. Multi-hire biometrics builds ahead of pivotal trials are a routine engagement.
Director of Biostatistics with adaptive design experience needed ahead of a Phase 2/3 seamless trial. Two retained firms had failed across six months.
Mapped 24 adaptive design-experienced biostatistics leaders nationally. Senior recruiter ran targeted outbound, presented a four-person shortlist in 13 days.
Offer accepted in 21 days. Adaptive design was finalized in the trial protocol on time.
"Recruits Lab understood the science from day one. They sent four interview-ready candidates inside two weeks after our internal team had spent three months on the role."
"Their subscription model let us close three scientific hires in a single quarter for less than what a single retained search would have cost us."
Yes. RWE and HEOR analytics are adjacent practice areas.
Yes. Pharmacometrics and PK/PD modeling are adjacent searches, often run on the same subscription.
Yes. Submission lead biostatistics roles are a frequent search profile.
Yes. We screen explicitly for the operational shift.
Yes. ML-augmented biostatistics is a growing area in our practice.
Every placement carries a 90-day replacement guarantee. If a hire leaves or does not work out within the first 90 days, we run the search again at no additional fee.
Yes. We sign NDAs and routinely run confidential and stealth-mode searches for executive replacements, sensitive program leads, and pre-launch hires.
Book a free 30-minute hiring strategy review using the CTA on this page. We will scope the role, suggest a sourcing approach, and quote a subscription or contingency option that fits your stage.
Compensation data, hiring playbooks, case studies, and related recruiting specialties.
Four ways to engage. Pick whichever matches where you are.
30-minute strategy review with a senior recruiter. Free, no commitment.
Get startedTell us about the role. We respond with a calibration call within 24 hours.
Get startedSend a job description. We confirm fit and quote a subscription or contingency engagement.
Get startedSenior candidates: get represented to our active hiring pipeline.
Get startedRelated Resources
Hand-picked salary guides, market reports, and recruiter pages related to this topic. Authored by Darren Nelson and the Recruits Lab team.
Schedule a free 30-minute Hiring Strategy Review and walk away with a clear plan tailored to your roles.